Literature DB >> 17359495

Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast.

Andrea L Manuell1, Maria Verónica Beligni, John H Elder, David T Siefker, Miller Tran, Annika Weber, Thomas L McDonald, Stephen P Mayfield.   

Abstract

We have engineered the chloroplast of eukaryotic algae to produce a number of recombinant proteins, including human monoclonal antibodies, but, to date, have achieved expression to only 0.5% of total protein. Here, we show that, by engineering the mammalian coding region of bovine mammary-associated serum amyloid (M-SAA) as a direct replacement for the chloroplast psbA coding region, we can achieve expression of recombinant protein above 5% of total protein. Chloroplast-expressed M-SAA accumulates predominantly as a soluble protein, contains the correct amino terminal sequence and has little or no post-translational modification. M-SAA is found in mammalian colostrum and stimulates the production of mucin in the gut, acting in the prophylaxis of bacterial and viral infections. Chloroplast-expressed and purified M-SAA is able to stimulate mucin production in human gut epithelial cell lines. As Chlamydomonas reinhardtii is an edible alga, production of therapeutic proteins in this organism offers the potential for oral delivery of gut-active proteins, such as M-SAA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359495     DOI: 10.1111/j.1467-7652.2007.00249.x

Source DB:  PubMed          Journal:  Plant Biotechnol J        ISSN: 1467-7644            Impact factor:   9.803


  48 in total

1.  The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics.

Authors:  Beth A Rasala; Stephen P Mayfield
Journal:  Bioeng Bugs       Date:  2011 Jan-Feb

2.  Haematococcus as a promising cell factory to produce recombinant pharmaceutical proteins.

Authors:  Amir Ata Saei; Parisa Ghanbari; Abolfazl Barzegari
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

3.  Biofuels from algae: challenges and potential.

Authors:  Michael Hannon; Javier Gimpel; Miller Tran; Beth Rasala; Stephen Mayfield
Journal:  Biofuels       Date:  2010-09       Impact factor: 2.956

Review 4.  Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses.

Authors:  Beth A Rasala; Stephen P Mayfield
Journal:  Photosynth Res       Date:  2014-03-22       Impact factor: 3.573

Review 5.  Chlamydomonas as a model for biofuels and bio-products production.

Authors:  Melissa A Scranton; Joseph T Ostrand; Francis J Fields; Stephen P Mayfield
Journal:  Plant J       Date:  2015-02-18       Impact factor: 6.417

Review 6.  Plastid biotechnology: food, fuel, and medicine for the 21st century.

Authors:  Pal Maliga; Ralph Bock
Journal:  Plant Physiol       Date:  2011-01-14       Impact factor: 8.340

7.  Microalgae as platforms for production of recombinant proteins and valuable compounds: progress and prospects.

Authors:  Yangmin Gong; Hanhua Hu; Yuan Gao; Xudong Xu; Hong Gao
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-01       Impact factor: 3.346

Review 8.  Manipulation of the microalgal chloroplast by genetic engineering for biotechnological utilization as a green biofactory.

Authors:  Yong Min Kwon; Kyung Woo Kim; Tae-Young Choi; Sun Young Kim; Jaoon Young Hwan Kim
Journal:  World J Microbiol Biotechnol       Date:  2018-11-26       Impact factor: 3.312

Review 9.  The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins.

Authors:  Fariba Akbari; Morteza Eskandani; Ahmad Yari Khosroushahi
Journal:  World J Microbiol Biotechnol       Date:  2014-08-13       Impact factor: 3.312

10.  Comparison of effectiveness of 5'-regulatory sequences in transplastomic tobacco chloroplasts.

Authors:  I M Gerasymenko; Y V Sheludko; A A Klebanovych; V A Rudas; A M Shakhovsky; T M Klein; N V Kuchuk
Journal:  Transgenic Res       Date:  2016-08-26       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.